ask="2.00"
ask_size="500"
average_daily_volume="82481"
bid="0.62"
bid_size="400"
book_value="0.73"
change="+0.02"
change_from_200_day_moving_average="-0.24"
change_from_50_day_moving_average="-0.12"
change_from_52_week_high="-0.86"
change_From_52_week_low="0.21"
change_in_percent="+1.79%"
close="1.14"
dividend_pay_date="11/8/2012"
dividend_per_share="0.00"
dividend_yield="0.00"
earnings_per_share="-0.81"
ebitda="-30.60M"
eps_estimate_current_year="-0.85"
eps_estimate_next_quarter="-0.20"
eps_estimate_next_year="-0.86"
ex_dividend_date="11/9/2012"
float_shares="30552000"
high="1.18"
high_52_weeks="2.00"
last_trade_date="2/10/2017"
last_trade_price="1.14"
last_trade_size="473"
last_trade_time="4:00pm"
low="1.09"
low_52_weeks="0.93"
market_capitalization="44.06M"
moving_average_200_day="1.38"
moving_average_50_day="1.26"
name="Aviragen Therapeutics
Inc."
notes="N/A"
one_year_target_price="4.17"
open="1.11"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-17.58%"
percent_change_from_50_day_moving_average="-9.35%"
percent_change_from_52_week_high="-43.00%"
percent_change_from_52_week_low="+22.58%"
previous_close="1.12"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="1.54"
price_per_sales="4.42"
revenue="9.80M"
shares_outstanding="38649000"
short_ratio="1.26"
stock_exchange="NMS"
symbol="AVIR"
volume="166746"
weeks_range_52="0.93 - 2.00"
